Revenue $3.10B, up 10.0% on a year earlier. Diluted EPS $2.78 against $2.16.
| Q3 FY26 | Q2 FY26 | Q3 FY25 | Year over year | |
|---|---|---|---|---|
| Revenue | $3.10B | $3.04B | $2.82B | +10.0% |
| Operating income | $479.00M | $459.00M | $386.00M | +24.1% |
| Net income | $312.00M | $320.00M | $245.00M | +27.3% |
| Diluted EPS | $2.78 | $2.84 | $2.16 | |
| Operating cash flow | $611.00M | $597.00M | $563.00M | +8.5% |
| Capital expenditures | -$166.00M | -$138.00M | -$144.00M | |
| Free cash flow | $445.00M | $459.00M | $419.00M | +6.2% |
| Dividend per share | $0.86 | $0.86 | $0.80 |
| Q3 FY26 | Q3 FY25 | Year over year | |
|---|---|---|---|
| Net revenues growth | 10% | 13.18% | |
| Revenue per requisition growth | -4.2% | 0.8% |
The week's biggest guidance misses, KPI surprises and one chart.
Stock Atlas, “Quest Diagnostics (DGX) Q3 FY26 earnings: results and KPIs”, stockatlas.com/companies/DGX/earnings/2026-q3/, data as of 3 November 2026. Links to this page are welcome.
